📰 Abt News
Page 91 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
October 3, 2023
Sequent Asset Management LLC raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 25.8% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,737 shares of the healthcare product maker’s stock after purchasing an additional 1,383 shares during the period. Abbott Laboratories […]
October 3, 2023
Nilsine Partners LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,704 shares of the healthcare product maker’s stock after purchasing an additional 432 shares during […]
October 3, 2023
Mcdaniel Terry & Co. reduced its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,398 shares of the healthcare product maker’s stock after selling 227 shares during the […]
October 3, 2023
Stiles Financial Services Inc increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 9.3% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,372 shares of the healthcare product maker’s stock after purchasing an additional 1,911 shares during the […]
October 3, 2023
Mcrae Capital Management Inc. grew its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 6,312 shares of the healthcare product maker’s stock after purchasing an additional 200 shares during the period. […]
October 3, 2023
Brown Financial Advisory purchased a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 1,904 shares of the healthcare product maker’s stock, valued at approximately $208,000. Abbott Laboratories comprises 0.2% of Brown Financial Advisory’s investment portfolio, making the […]
October 3, 2023
Tempus Wealth Planning LLC lessened its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 9.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,271 shares of the healthcare product maker’s stock after selling 240 shares during […]
October 3, 2023
Hills Bank & Trust Co grew its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% during the 2nd quarter, Holdings Channel reports. The firm owned 43,666 shares of the healthcare product maker’s stock after purchasing an additional 370 shares during the period. Hills Bank & Trust Co’s holdings in Abbott Laboratories […]
October 3, 2023
Purus Wealth Management LLC increased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 51.6% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,387 shares of the healthcare product maker’s stock after buying an additional 2,856 shares during the quarter. […]
October 3, 2023
Summit Financial Strategies Inc. trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,557 shares of the healthcare product maker’s stock after selling 215 shares during the period. […]